Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03610724
Title Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients (BIANCA)
Acronym BIANCA
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | CAN | AUT | AUS

Facility Status City State Zip Country Details
Childrens Hospital Los Angeles Los Angeles California 90027 United States Details
UCSF Medical Center San Francisco California 94143 United States Details
Johns Hopkins Oncology Center ORA Baltimore Maryland 21231 United States Details
Dana Farber Cancer Institute Dept.of DFCI Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center MSKCC (8) New York New York 10065 United States Details
Cinn Children Hosp Medical Center Cincinnati Ohio 45229-3039 United States Details
The Childrens Hospital of Philadelphia Drug Shipment Philadelphia Pennsylvania 19104 United States Details
University of Texas Southwestern Medical Center . Dallas Texas 75235 United States Details
Novartis Investigative Site Randwick New South Wales 2031 Australia Details
Novartis Investigative Site Parkville Victoria 3052 Australia Details
Novartis Investigative Site Wien A 1090 Austria Details
Novartis Investigative Site Toronto Ontario M5G 1X8 Canada Details
Novartis Investigative Site Copenhagen 2100 Denmark Details
Novartis Investigative Site Helsinki 00029 Finland Details
Novartis Investigative Site Paris 75019 France Details
Novartis Investigative Site Villejuif 94800 France Details
Novartis Investigative Site Muenster 48149 Germany Details
Novartis Investigative Site Monza MB 20900 Italy Details
Novartis Investigative Site Roma RM 00165 Italy Details
Kyoto University Hospital Sakyō-ku Kyoto 606 8507 Japan Details
Novartis Investigative Site Setagaya-ku Tokyo 157-8535 Japan Details
Prinses Maxima Centrum voor Kinderoncologie Utrecht CS 3584 Netherlands Details
Novartis Investigative Site Oslo 0424 Norway Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Madrid 28046 Spain Details
Novartis Investigative Site London WC1N 1EH United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field